paroxysmal nocturnal hemoglobinuria (PNH) | Page 8 | Aplastic Anemia & MDS International Foundation

paroxysmal nocturnal hemoglobinuria (PNH)

Regis Peffault de Latour, MD, PhD

Peffault de Latour, Regis
Hôpital Saint-Louis

Dr. Peffault de Latour is a full Professor of Hematology in the Hematology and Bone Marrow Transplant Department of the Saint-Louis Hospital, Paris Address Service Hématologie-Greffe, Hôpital Saint Louis

regis.peffaultdelatour@aphp.fr

2019 Patient & Family Conference (St. Louis Missouri)

Presentation materials from the 2019 AAMDSIF Patient & Family Conference in St. Louis, Missouri.

Event Date: 
Sat, 10/26/2019 - 7:30am
Conference Event Type: 

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Author(s): 
Stern RM, Connell NT
Primary Author: 
Stern RM
Journal Title: 
Therapeutic Advances in Hematology
Original Publication Date: 
Sep 2019

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare stem cell disorder characterized by

2019 Patient & Family Conference (Pittsburgh Area)

Conference materials from the 2019 Patient & Family Conference:  Pittsburgh area

Event Date: 
Sat, 09/21/2019 - 7:30am
Conference Event Type: 

Get involved with AAMDSIF!

There are many ways patients, families, caregivers, communities and friends can help support the Foundation in our search for a cure. Join us! 

Event Date: 
Tue, 12/31/2019 - 11:18pm
Community Event Type: